Ensign Peak Advisors »

Travere Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $20M 852k 23.90
2025-06-30 $13M 859k 14.80
2025-03-31 $8.9M 499k 17.92
2023-06-30 $1.7M 110k 15.36
2023-03-31 $2.5M 110k 22.49
2022-12-31 $1.6M 77k 21.03
2022-09-30 $2.4M 97k 24.64
2022-06-30 $1.9M 77k 24.23
2022-03-31 $286k 11k 25.81